trial

Evaluation of Metamemory in Patients With Schizophrenia

NCTId NCT03338179
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 120 (actual)
Sponsored by University Hospital, Clermont-Ferrand
Primary completion 2016-05-23
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
120 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2011-02-08
Primary completion
2016-05-23
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Judgement of learning evaluation

Sponsors

University Hospital, Clermont-FerrandLead Sponsor
LAPSCO, Psychology University, Blaise Pascal University, Clermont-Ferrand.Collaborator

Investigators

1
Isabelle JALENQUESPrincipal Investigator

Sites

1 total
Clermont-Ferrand, France

Facts & assertions

4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2016-05-23
Status
COMPLETED
relationships
The graph out of here
drug
Judgement of learning evaluation
drug
lead_sponsor
University Hospital, Clermont-Ferrand
company
collaborator
LAPSCO, Psychology University, Blaise Pascal University, Clermont-Ferrand.
company
indication
Schizophrenia
indication
Schizophrenia
indication
Aging
indication
investigator
Isabelle JALENQUES
person